WELCOME TO QClair In-Silico

Commited to make Drug discovery Faster

Why Choose QClair In-Silico?

QClair In-Silico is Artificial Inteligent SaaS which has been trained on state of the arts deep learning technology. Provides complete package for prediction of Protein-Ligand Interaction, Protein-Protein Interaction and Drug-Drug Interaction. Utilizing this package you can expedite your drug discovery process.

Learn More

Protein Ligand Interaction

Protein-ligand interaction involves a ligand binding to a protein, influencing processes like enzyme activity and signaling. It’s critical in drug discovery to optimize binding affinity and specificity. Experimental and computational studies of these interactions identify drug targets and refine compounds for therapeutic use.

Drug-Drug Interaction

Drug-drug interaction occurs when one drug alters another’s effects, impacting efficacy or causing adverse reactions. Classified as pharmacokinetic or pharmacodynamic, DDIs are crucial in ensuring patient safety. Predictive computational models and experimental validation help identify and mitigate potential interactions during drug development.

Protein-Protein Interaction

Protein-protein interactions are essential for cellular processes like signaling and metabolism. Dysregulated PPIs are linked to diseases, making them key therapeutic targets. Experimental methods and computational modeling aid in understanding their strength, specificity, and dynamics, driving the development of innovative treatments, including PPI inhibitors.